The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Application of Artificial Intelligence in Lung Cancer
Open accessAbstract
Lung cancer is the leading cause of malignancy-related mortality worldwide due to its heterogeneous features and diagnosis at a late stage. Artificial intelligence (AI) is good at handling a large volume of computational and repeated labor work and is suitable for assisting doctors in analyzing image-dominant diseases like lung cancer. Scientists have shown long-standing efforts to apply AI in lung cancer screening via CXR and chest CT since the 1960s. Several grand challenges were held to find the best AI model. Currently, the FDA have approved several AI programs in CXR and chest CT reading, which enables AI systems to take part in lung cancer detection. Following the success of AI application in the radiology field, AI was applied to digitalized whole slide imaging (WSI) annotation. Integrating with more information, like demographics and clinical data, the AI systems could play a role in decision-making by classifying EGFR mutations and PD-L1 expression. AI systems also help clinicians to estimate the patient’s prognosis by predicting drug response, the tumor recurrence rate after surgery, radiotherapy response, and side effects. Though there are still some obstacles, deploying AI systems in the clinical workflow is vital for the foreseeable future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Evidence suggests AI might benefit diagnostic services by supporting decision-making, improving detection accuracy, reducing errors, increasing efficiency, and easing workforce burdens.13, 14, 15”
From Procurement and early deployment of artificial intelligence tools for chest diagnostics in NHS services in England: a rapid, mixed method evaluation (2025) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancer diagnostic approach
Poore, G. D., Kopylova, E., Zhu, Q., Carpenter, C., Fraraccio, S., Wandro, S., Kosciolek, T., Janssen, S., Metcalf, J., Song, S. J., et al. (2020) · Nature · doi:10.1038/s41586-020-2095-1 · Cited by 989
RetractedReduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
The cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092
Wang, X., Peng, Y., Lu, L., Lu, Z., Bagheri, M., & Summers, R. M. (2017) · 2017 IEEE Conference on Computer Vision and Pattern Recognition (CVPR) · doi:10.1109/cvpr.2017.369 · Cited by 4,616
The 2015 World Health Organization Classification of Lung Tumors
Travis, W. D., Brambilla, E. M., Nicholson, A. G., Yatabe, Y., Austin, J. H. M., Beasley, M. B., Chirieac, L. R., Đačić, S., Duhig, E., Flieder, D. B., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000630 · Cited by 4,532
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., Lammers, J.-W. J., Weenink, C., Yousaf-Khan, U., Horeweg, N., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911793 · Cited by 3,624
A general reinforcement learning algorithm that masters chess, shogi, and Go through self-play
Silver, D., Hubert, T., Schrittwieser, J., Antonoglou, I., Lai, M., Guez, A., Lanctot, M., Sifre, L., Kumaran, D., Graepel, T., et al. (2018) · Science · doi:10.1126/science.aar6404 · Cited by 3,562 · cited 2×
“This type of AI is famous for playing chess, shogi, and Go through self-play [69] or generating data with GANs [70].”
BackgroundMachine Learning Applications in Cancer Prognosis and Prediction
Kourou, K., Exarchos, T. P., Exarchos, K. P., Karamouzis, M. V., & Fotiadis, D. I. (2015) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2014.11.005 · Cited by 3,338
Ehteshami Bejnordi, B., Veta, M., Johannes van Diest, P., van Ginneken, B., Karssemeijer, N., Litjens, G., van der Laak, J. A. W. M., and the CAMELYON16 Consortium, Hermsen, M., Manson, Q. F., et al. (2017) · JAMA · doi:10.1001/jama.2017.14585 · Cited by 3,293
Coudray, N., Ocampo, P. S., Sakellaropoulos, T., Narula, N., Snuderl, M., Fenyö, D., Moreira, A. L., Razavian, N., & Tsirigos, A. (2018) · Nature Medicine · doi:10.1038/s41591-018-0177-5 · Cited by 2,930
Research works printed but not linked: 3
- Rajpurkar, P., Irvin, J., Zhu, K., Yang, B., Mehta, H., Duan, T., Ding, D., Bagul, A., Langlotz, C., and Shpanskaya, K. (2017). Chexnet: Radiologist-level pneumonia detection on chest x-rays with deep learning. arXiv.
- Nguyen, H.C., Le, T.T., Pham, H., and Nguyen, H.Q. (2021). VinDr-RibCXR: A Benchmark Dataset for Automatic Segmentation and Labeling of Individual Ribs on Chest X-rays. arXiv.
- Jain, S., Agrawal, A., Saporta, A., Truong, S.Q., Bui, T., Chambon, P., Zhang, Y., Lungren, M.P., Ng, A.Y., and Langlotz, C. (2021). RadGraph: Extracting Clinical Entities and Relations from Radiology Reports. arXiv.
Cited by
Sorted by citations
Artificial Intelligence in Pharmaceutical and Healthcare Research
Bhattamisra, S. K., Banerjee, P., Gupta, P., Mayuren, J., Patra, S., & Candasamy, M. (2023) · Big Data and Cognitive Computing · doi:10.3390/bdcc7010010 · Cited by 298
Shaping the future of AI in healthcare through ethics and governance
Bouderhem, R. (2024) · Humanities and Social Sciences Communications · doi:10.1057/s41599-024-02894-w · Cited by 218
Artificial Intelligence and Lung Cancer: Impact on Improving Patient Outcomes
Gandhi, Z., Gurram, P., Amgai, B., Lekkala, S. P., Lokhandwala, A., Manne, S., Mohammed, A. S., Koshiya, H., Dewaswala, N., Desai, R., et al. (2023) · Cancers · doi:10.3390/cancers15215236 · Cited by 144
Deep Machine Learning for Medical Diagnosis, Application to Lung Cancer Detection: A Review
Gayap, H. T., & Akhloufi, M. A. (2024) · BioMedInformatics · doi:10.3390/biomedinformatics4010015 · Cited by 136
Advances of Artificial Intelligence in Anti-Cancer Drug Design: A Review of the Past Decade
Wang, L., Song, Y., Wang, H., Zhang, X., Wang, M., He, J., Li, S., Zhang, L., Li, K., & Cao, L. (2023) · Pharmaceuticals · doi:10.3390/ph16020253 · Cited by 86
Metadata
- Authors
- Chiu, H.-Y., Chao, H.-S., & Chen, Y.-M.
- Affiliations
- National Yang Ming Chiao Tung University (TW)
- Corresponding author
- Chao, Heng-Sheng
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2022-03-08
- Volume
- 14
- Issue
- 6
- Pages
- 1370
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC8946647
- OpenAlex
- W4220889814
- Cited by
- 138
- References
- 138
- Citations by year
- 2026: 21 · 2025: 47 · 2024: 37 · 2023: 29 · 2022: 4
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Ministry of Science and Technology (MOST 110-2321-B-075-001)
- Topics
- Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Keywords
- lung cancer, artificial intelligence, lung cancer screening, chest CT, chest radiography, whole slide imaging, EGFR mutation, PD-L1 expression, outcome prediction, drug response prediction, clinical decision support
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review